Iranian Journal of Materials Science and Engineering

---

Abstract:

fabricated. Modifications carried out in different parts of the old system in order to control most

of the growth parameters with more accuracy. The fabricated system was used to grow sapphire

single crystals with almost 10 mm in diameter and 50 mm in length. The crystallinity and

structure of the grown crystals were characterized by computer aided single crystal X-ray

diffraction technique.

A Verneuil system, more sophisticated than a conventional one, has been designed and

---

---

Abstract: The linear expansion, early-age compressive strength and setting times of the binary mixtures of gypsum and Portland cement clinkers of relatively low C3A-contents were investigated. For this reason, type 1, 2, and 5 of Portland cement-clinkers were selected and a number of binary mixtures were designed. At relatively lower percentages of gypsum (about 5%), the early strength behavior is improved. Results obtained for compressive strength of mixtures with 5% gypsum confirm the possibility of achieving 28- and 90-day compressive strengths up to values higher than 100 MPa and 130 MPa, respectively. At relatively higher percentages of gypsum (more than 25%), excessive expansion caused by ettringite formation results in the formation of micro-cracks effectively weakening the strength behavior. The work suggests that type S expansive cements could be produced from Portland cement clinkers of relatively low C3Acontents.

---

Abstract: A thermodynamic model was used to find out the optimum temperature for the growth of ZnS single crystals in closed ampoules by chemical vapor transport technique. Based on this model 1002 °C was found to be optimum temperature for 2 mg/cm3 concentration of transporting agent (iodine). ZnS Crystals were grown in optimum (1002 °C) and non-optimum (902 °C and 1102 °C) temperatures. The composition structure and microstructure of the grown crystals were studied by Atomic absorption spectroscopy, X-ray diffraction and Scanning electron microscopy measurements. Properties of the grown crystals were correlated to the growth conditions especially a stability in mass transport along the closed tube length.

---

Well crystallized pure calcium zirconate (CaZrO3 ) nanopowder was successfully synthesized using the molten-salt method. CaCl2 , Na 2CO3, micro-ZrO 2and nano-ZrO 2 were used as starting materials. On heating, Na2CO3 reacted with CaCl 2to form NaCl and CaCO 3. Nano CaZrO 3 was formed by reacting equimolar amounts of in situformed CaCO 3 (or CaO) and ZrO 2 in molten Na 2CO3-NaCl eutectic mixture. CaZrO 3 particle size and synthesis temparture was tailored as a function of ZrO 2particle size. Due to the usage of nano-ZrO 2 , the molten salt synthesis (MSS) temperature was decreased and possible impurity phases in the final product were suppressed. The synthesis temperature was lowered to 800°C and soaking time of the optimal synthesis condition was reduced to 3h. After washing with hot-distilled water, the n-ZrO2sample heated at 800°C for 3h, was single phase CaZrO 3with 70-90 nm in particle size, while the m-ZrO 2sample heated at 1000°C for 3h, was single phase CaZrO 3 with 250-400 nm in particle size. Based on the TEM observation and thermodynamic analysis, the synthesized CaZrO 3 grains retained the morphology of the ZrO2 nanopowders, which indicated that a template formation mechanism play a dominant role in synthesis process

---

Neoplastic cells have co-opted inflammatory receptors and signaling molecules that potentiate inflammation. Activated inflammatory pathways lead to neo-angiogenesis, lymph-angiogenesis, immunosuppression, tumor growth, proliferation and metastasis. This cancer-sustaining inflammation is a critical target to arrest cancer growth. Multiple drug resistance, high cost, low oral bioavailability and serious side effects have rendered conventional cytotoxic chemotherapeutics less impressive. The aim of this research was to achieve cancer debulking and proliferation prevention by limiting ‘cancer-sustaining’ tumor niche inflammation through non-conventional oral approach employing anti-inflammatory agents and avoiding conventional cytotoxic agents. Synergistic anti-inflammatory agents, i.e. celecoxib as selective COX-2 inhibitor and montelukast as cysteinyl leukotriene receptor antagonist, were selected. Silver nanoparticles (AgNPs) were used as nanocarriers because of their efficient synergistic anti-neoplastic effects and excellent oral drug delivery potential. Specifically, selected drugs were co-conjugated onto AgNPs. Synthesized nanoparticles were then surface-modified with poly(vinyl alcohol) to control particle size, avoid opsonization/preferred cellular uptake and improve dispersion. Surface plasmon resonance analysis, particle size analysis, DSC, TGA, XRD, FTIR and LIBS analysis confirmed the successful conjugation of drugs and efficient polymer coating with high loading efficiency. In-vitro, the nanoparticles manifested best and sustained release in moderately acidic (pH 4.5) milieu enabling passive tumor targeting potential. In-vivo, synthesized nanoparticles exhibited efficient dose-dependent anti-inflammatory activity reducing the dose up to 25-fold. The formulation also manifested hemo-compatibility, potent anti-denaturation activity and dose-dependent in-vitro and in-vivo anti-cancer potential against MCF-7 breast cancer and Hep-G2 liver cancer cell lines in both orthotopic and subcutaneous xenograft cancer models. The anti-inflammatory nanoparticles manifested tumor specific release potential exhibiting selective cytotoxicity at cancerous milieu with slightly acidic environment and activated inflammatory pathways. The formulation displayed impressive oral bioavailability, sustained release, negligible cytotoxicity against THLE-2 normal human hepatocytes, low toxicity (high LD₅₀) and wide therapeutic window. Results suggest promise of developed nanomaterials as hemo-compatible, potent, cheaper, less-toxic oral anti-inflammatory and non-conventional anti-cancer agents.